Chemokine receptor oligomerization: functional considerations

Current Opinion in Pharmacology

Volumn 10, Issue 1, 2010, Pages 38-43

  Thelen, Marcus ^a   Muñoz, Laura Martinez ^b   Rodríguez Frade, José Miguel ^b   Mellado, Mario ^b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; G PROTEIN COUPLED RECEPTOR; GLYCOSAMINOGLYCAN;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENCE RESONANCE ENERGY TRANSFER; HOMEOSTASIS; IN VIVO STUDY; INFLAMMATION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW;

CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTORS, CHEMOKINE;

EID: 72449124327     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.09.004     Document Type: Review

References (51)

1. Mackay C.R. Chemokines: immunology's high impact factors. Nat Immunol 2 (2001) 95-101
2. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
3. Sallusto F., Lanzavecchia A., and Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19 (1998) 568-574
4. Homey B., Müller A., and Zlotnik A. Chemokines: agents for the immunotherapy of cancer?. Nat Rev Immunol 2 (2002) 175-184
5. Reiche E.M., Bonametti A.M., Voltarelli J.C., Morimoto H.K., and Watanabe M.A. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1). Cur Med Chem 14 (2007) 1325-1334
6. Johnson Z., Proudfoot A.E., and Handel T.M. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 16 (2005) 625-636
7. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
8. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., and Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
9. Haraldsen G., and Rot A. Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines. Eur J Immunol 36 (2006) 1659-1661
10. Schwartz T.W., Frimurer T.M., Holst B., Rosenkilde M.M., and Elling C.E. Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu Rev Pharmacol Toxicol 46 (2006) 481-519
11. Rajarathnam K., Sykes B.D., Kay C.M., Dewald B., Geiser T., Baggiolini M., and Clark-Lewis I. Neutrophil activation by monomeric interleukin-8. Science 264 (1994) 90-92. The paper elegantly shows that obligate chemokine monomers retain full stimulatory activity.
12. Jin H., Shen X., Baggett B., Kong X., and LiWang P.J. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor. J Biol Chem 282 (2007) 27976-27983
13. Thelen M., and Stein J.V. How chemokines invite leukocytes to dance. Nat Immunol 9 (2008) 953-959. The authors discuss the potential influence of chemokine/chemokine receptor oligomers.
14. Nesmelova I.V., Sham Y., Gao J., and Mayo K.H. CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations. J Biol Chem 283 (2008) 24155-24166
15. Laurence J.S., Blanpain C., Burgner J.W., Parmentier M., and LiWang P.J. CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry 39 (2000) 3401-3409
16. Gouwy M., Struyf S., Catusse J., Proost P., and Van D.J. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J Leukoc Biol 76 (2004) 185-194
17. Paoletti S., Petkovic V., Sebastiani S., Danelon M.G., Uguccioni M., and Gerber B.O. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 105 (2005) 3405-3412
18. Gouwy M., Struyf S., Noppen S., Schutyser E., Springael J.Y., Parmentier M., Proost P., and Van Damme J. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol Pharmacol 742 (2008) 485-495. The authors show that chemokines that compete for related receptors and use similar signaling pathways do not synergize. The data indicate that receptor signaling capacity must remain intact to guarantee chemokine synergy.
19. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 100 (2003) 1885-1890. Both GAG binding and the ability to form higher order oligomers are shown to be essential for the in vivo activity of specific chemokines.
20. Koenen R.R., von Hundelshausen P., Nesmelova I.V., Zernecke A., Liehn E.A., Sarabi A., Kramp B.K., Piccinini A.M., Paludan S.R., Kowalska M.A., et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15 (2009) 97-103. The authors establish the in vivo relevance of chemokine heteromers and discuss their therapeutic potential.
21. Ernst O.P., Gramse V., Kolbe M., Hofmann K.P., and Heck M. Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc Natl Acad Sci USA 104 (2007) 10859-10864
22. Kuszak A.J., Pitchiaya S., Anand J.P., Mosberg H.I., Walter N.G., and Sunahara R.K. Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem (2009) PMID: 19542234
23. Issafras H., Angers S., Bulenger S., Blanpain C., Parmentier M., Labbé-Jullié C., Bouvier M., and Marullo S. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 277 (2002) 34666-34673
24. Singer I.I., Scott S., Kawka D.W., Chin J., Daugherty B.L., DeMartino J.A., DiSalvo J., Gould S.L., Lineberger J.E., Malkowitz L., et al. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol 75 (2001) 3779-3790
25. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26 (2005) 131-137
26. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., and Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 272 (1997) 30603-30606
27. Hamatake M., Aoki T., Futahashi Y., Urano E., Yamamoto N., and Komano J. Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis. Cancer Sci 100 (2009) 95-102
28. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421 (2003) 127-128
29. Dar A., Goichberg P., Shinder V., Kalinkovich A., Kollet O., Netzer N., Margalit R., Zsak M., Nagler A., Hardan I., et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 6 (2005) 1038-1046
30. Carriba P., Navarro G., Ciruela F., Ferré S., Casadó V., Agnati L., Cortés A., Mallol J., Fuxe K., Canela E.I., et al. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 5 (2008) 727-733. A seminal study that describes a novel method to measure heteromeric membrane protein complexes.
31. Ciruela F. Fluorescence-based methods in the study of protein-protein interactions in living cells. Curr Opin Biotechnol 19 (2008) 338-343
32. Hernanz-Falcón P., Rodríguez-Frade J.M., Serrano A., Juan D., del Sol A., Soriano S.F., Roncal F., Gómez L., Valencia A., Martínez-A C., and Mellado M. Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 5 (2004) 216-223. Using CCR5 as a model, the authors show that TM1 and TM4 domains are key regions in the interaction surface between chemokine receptors.
33. Wang J., He L., Combs C.A., Roderiquez G., and Norcross M.A. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol Cancer Ther 5 (2006) 2474-2483. A synthetic peptide of the CXCR4 TM4 domain reduces energy transfer between CXCR4 molecules, inhibits CXCL12-induced actin polymerization, and blocks chemotaxis of tumor cells.
34. Guo W., Shi L., Filizola M., Weinstein H., and Javitch J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci USA 102 (2005) 17495-17500. The authors use a cystein scan and crosslink approach to reveal distinct conformations of the TM4 forming the dimer interface in resting and activated receptors.
35. Kozak S.L., Heard J.M., and Kabat D. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J Virol 76 (2002) 1802-1815
36. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., and Stevens R.C. High-resolution crystal structure of an engineered human b2-adrenergic G protein coupled receptor. Science 318 (2007) 1258-1265
37. Wilson S., Wilkinson G., and Milligan G. The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J Biol Chem 280 (2005) 28663-28674
38. Percherancier Y., Berchiche Y.A., Slight I., Volkmer-Engert R., Tamamura H., Fujii N., Bouvier M., and Heveker N. Bioluminiscence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 280 (2005) 9895-9903
39. Babcock G.J., Farzan M., and Sodroski J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 278 (2003) 3378-3385
40. Blanpain C., Vanderwinden J., Cihak J., and Mack M. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol Biol Cell 13 (2002) 723-737
41. Oppermann M., Mack M., Proudfoot A.E., and Olbrich H. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 274 (1999) 8875-8885
42. Ogilvie P., Thelen S., Moepps B., Gierschik P., Da Silva Campos A.C., Baggiolini M., and Thelen M. Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway. J Immunol 172 (2004) 6715-6722
43. El-Asmar L., Springael J.Y., Ballet S., Urizar E., Vassart G., and Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67 (2004) 460-469
44. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57 (2005) 289-298
45. Contento R.L., Molon B., Boularan C., Pozzan T., Manes S., Marullo S., and Viola A. CXCR4-CCR5: a couple modulating T cell functions. Proc Natl Acad Sci USA 105 (2008) 10101-10106
46. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (1996) 833-835
47. Sohy D., Parmentier M., and Springael J.Y. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 282 (2007) 30060-30062
48. Chabre M., Deterre P., and Antonny B. The apparent cooperativity of some GPCRs does not necessarily imply dimerization. Trends Pharmacol Sci 30 (2009) 182-187
49. Mellado M., Rodríguez-Frade J.M., Vila-Coro A.J., Fernández S., Martín de Ana A., Jones D.R., Torán J.L., and Martínez-A C. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20 (2001) 2497-2507. The authors show the functional differences triggered by chemokine receptor homo-and heterodimers.
50. Levoye A., Balabanian K., Baleux F., Bachelerie F., and Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113 (2009) 6085-6093. The study provides evidence for heteromer-induced differences in G-protein-coupling.
51. Sierro F., Biben C., Martínez-Muñoz L., Mellado M., Ransohoff R.M., Li M., Woehl B., Leung H., Groom J., Batten M., et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104 (2007) 14759-14764